Our Overall Current Knowledge of Covid 19: An Overview

Asma Tadj; Seddiki Sidi Mohammed Lahbib

doi:10.54034/mic.e1262

Authors

Asma Tadj Laboratory for Sustainable Management of Natura Ressources In Arid And Semi-Arid Areas. University Center of Naâma
Seddiki Sidi Mohammed Lahbib University Center of Naâma, Algeria; University of Tlemcen, Algeria https://orcid.org/0000-0001-6055-5137

DOI:

https://doi.org/10.54034/mic.e1262

Keywords:

COVID-19, SARS-CoV2, pandemic

Abstract

The World Health Organization (WHO) declared COVID-19 as a public health epidemic emergency of international concern in March 2020. In just two years, this pandemic has invaded most countries and killed more than 4,800,000. The evolution of the number of cases and contaminations per day remains alarming. In May 2021, the bar of 400,000 new cases was crossed in India; this represents the highest daily number of cases recorded by a country in the history of the COVID-19 pandemic. In addition, new variants of the virus emerged in some countries. The international scientific and political community has organized itself and engaged in a race against time to find possible remedies. During this period, when people were forced to confine themselves to their homes, the way of life changed remarkably. From the declaration of the pandemic to the conception of the first vaccine, people are still in shock. This article is a short-review that explains in general what the COVID-19; the origin, biology and genetics as well as the mode of transmission and contamination of the coronavirus are discussed.

References

World Health Organization. 2020a. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19), Geneva. 2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-COVID-19-final-report.pdf. Accessed February 16–24, 2020.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395: 497–506. DOI: 10.1016/S0140-6736(20)30183-5.

World Health Organization. 2020b. - Naming the Coronavirus Disease (COVID-19) and the Virus that Causes it. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(COVID-2019)-and-the-virus-thatcauses-it. Accessed June 24, 2020. - Coronavirus-2019 disease outbreak (COVID-19). https://www.who.int/fr/emergencies/diseases/novel-coronavirus-2019. Accessed October, 2021.

Almeida JD, Berry DM., Cunningham CH, Hamre D, Hofstad MS, Mallucci L, et al. Virology: Coronaviruses. Nature. 1968, 220, 650. doi: 10.1038/220650b0

Almeida JD, Tyrrell DA. The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol. 1967, 1(2): 175-8. doi: 10.1099/0022-1317-1-2-175. PMID 4293939.

Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCo. Viruses. 2020, 12(2): 135. doi: 10.3390/v12020135.

World Health Organization. 2020c. Novel Coronavirus(2019-nCoV) Situation Report - 10. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10-ncov.pdf?sfvrsn=d0b2e480_2. Accessed May 05, 2020.

Rehman SU, Shafique L, Ihsan A, Liu Q. Evolutionary trajectory for the emergence of novel coronavirus SARS-CoV-2. Pathogens. 2020, 9(3):240. doi:10.3390/pathogens9030240.

Trougakos1 IP, Stamatelopoulos K, Terpos E , Tsitsilonis OE, Aivalioti E, et al. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications. J Biomed Sci. 2020, 28:9. https://doi.org/10.1186/s12929-020-00703-5

Guan W-J, Ni ZY, Hu Y, Liang W-H, Ou C-Q, He J-X et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020, 382: 1708-20. doi: 10.1056/NEJMoa2002032.

Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020, M20-0504. doi: 10.7326/M20-0504.

World Health Organization. 2020d. Symptoms of COVID-19. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-coronaviruses#:~:text=symptoms. Accessed June 22, 2020.

Chang Fe-Y, Chen H-C, Chen P-J, Ho M-S, Hsieh S-L, et al. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19). J Biomed Sci. 2020, 27:72. https://doi.org/10.1186/s12929-020-00663-w

Van Doremalen N, Bushmaker T, Morris D, Holbrook M, Gamble A, Williamson B, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020, 382(16):1564-1567. https://doi.org/10.1056/NEJMc2004973

Li Y-K, Peng S, Li L-Q, Wang Q, Ping W, Zhang N, et al. Clinical and transmission characteristics of COVID-19 - a retrospective study of 25 cases from a single thoracic surgery department. Curr Med Sci. 2020, 1-6. https://doi.org/10.1007/s11596-020-2176-2

Huang R, Zhao H, Wang J, Yan X, Shao H, Wu C. A family cluster of COVID-19 involving an asymptomatic case with persistently positive SARS-CoV-2 in anal swabs. Travel Med Infect Dis. 2020, 38: 101745. doi: 10.1016/j.tmaid.2020.101745.

Xing Y. Prolonged viral shedding in feces of pediatric patients with coronavirus disease. J Microbiol Immunol Infect. 2019, 53(3):473-480. https://doi.org/10.1016/j.jmii.2020.03.021

Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA. 2020; https://doi.org/10.1001/jama.2020.3227

Azzi L, Carcano G, Gianfagna F, Grossi P, Dalla Gasperina D, Genoni A, et al. Saliva is a reliable tool to detect SARS-CoV-2. J Infect. 2020, 81(1): e45-e50 https://doi.org/10.1016/j.jinf.2020.04.005

Li D, Jin M, Bao P, Zhao W, Zhang S, Clinical characteristics and results of semen tests among men with coronavirus disease 2019. JAMA Netw Open. 2020, 3(5): e208292. https://doi.org/10.1001/jamanetworkopen.2020.8292

Park WB, Kwon NJ, Choi SJ, Kang CK, Choe PG, Kim JY, et al. Virus isolation from the first patient with SARS-CoV-2 in Korea. J Korean Med Sci. 2020, 35(7): e84. https://doi.org/10.3346/jkms.2020.35.e84

Finlay BB, See RH, Brunham RC, Rapid response research to emerging infectious diseases: lessons from SARS. Nat Rev Microbiol. 2004, 2(7): 602-7. doi: 10.1038/nrmicro930.

Khailany RA, Safdar M, Ozaslan M, Genomic characterization of a novel SARS-CoV-2. Gene Rep. 2020, 19:100682. doi:10.1016/j.genrep.2020.100682.

Del Carpio-Orantes L. Zika and Novel Coronavirus 2019 (2019-nCoV): Pandemic Viruses Sharing Similarities. Arch Clin Infect Dis. 2020, 15(3): e103011. doi: 10.5812/archcid.103011.

Chen Y, Liu Q, Guo D. Coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 2020, 92(4): 418-423. https://doi.org/10.1002/jmv.25681

Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol. 2020, 79: 104212. doi: 10.1016/j.meegid.2020.104212

Kumar S, Nyodu R, Maurya VK, Saxena SK. Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). In: Saxena SK, edithor. Coronavirus Disease 2019 (COVID-19). Medical Virology: From Pathogenesis to Disease Control. Singapore: Springer. 2020, 23-31

Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses. 2015, 1282:1-23. doi: 10.1007/978-1-4939-2438-7_1.

Lu R, Xiang Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020, 395: 565–74. https://doi.org/10.1016/S0140-6736(20)30251-8

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020, 181(2): 271-280.e8. doi: 10.1016/j.cell.2020.02.052

Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science. 2020, 368(6489): 409-412. doi: 10.1126/science.abb3405.

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020, 367(6483):1260-1263. doi: 10.1126/science.abb2507

Masters PS. The molecular biology of coronaviruses. Adv Virus Res. 2006, 66:193-292. doi: 10.1016/S0065-3527(06)66005-3

Mousavizadeh L, Ghasemi S. Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect. 2021, 54(2):159-163. https://doi.org/10.1016/j.jmii.2020.03.022

Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016, 3(1):237-261. doi: 10.1146/annurev-virology-110615-042301

Belouzard S, Millet JK, Licitra BN, Whittaker GR. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012, 4(6):1011-33. doi: 10.3390/v4061011.

Liang Y, Wang M-L, Chien C-S, Yarmishyn AA, Yang Y-P, Lai W-Y, et al. Highlight of immune pathogenic response and hematopathologic effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 infection. Front Immunol. 2020, 11: 1022. doi: 10.3389/fimmu.2020.01022.

Martinez RM. Clinical Samples for SARS-CoV-2 Detection: Review of the Early Literature. Clin Microbiol Newsl. 2020, 42(15):121-127. doi: 10.1016/j.clinmicnews.2020.07.001

Kumar R, Nagpal S, Kaushik S, Mendiratta S. COVID-19 diagnostic approaches: different roads to the same destination. Virusdisease. 2020, 31(2): 97–105. doi: 10.1007/s13337-020-00599-7.

Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. 2020, 295(1):202-207. https://doi.org/10.1148/radiol.2020200230

Ajlan AM, Ahyad RA, Jamjoom LG, Alharthy A, Madani TA. Middle east respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings. Am J Roentgenol. 2014, 203(4):782-7. https://doi.org/10.2214/AJR.14.13021

Ooi GC, Khong PL, Muller NL, Yiu WC, Zhou LJ, Ho JCM, et al. Severe acute respiratory syndrome: temporal lung changes at thin-section CT in 30 patients. Radiology. 2004, 230(3):836-44. doi: 10.1148/radiol.2303030853.

Pecho-Silva1 S, Barboza JJ, Navarro-Solsol AC, Rodriguez-Morales AJ, Bonilla-Aldana DK, Panduro-Correa V. SARS-CoV-2 Mutations and Variants: what do we know so far? Microbes Infect Chemother. 2021, 1, 1-8, e1256. https://doi.org/10.54034/mic.e1256